Sana Biotechnology, Inc.
Status: Publicly traded
Direct answer
Sana Biotechnology, Inc. is publicly traded on NASDAQ under the ticker SANA.
Sana Biotechnology, Inc. is a biotechnology firm focused on creating treatments using engineered cells. The company develops advanced ex vivo and in vivo cell engineering platforms to address a range of conditions with significant unmet medical needs, including various cancers, diabetes, central nervous system disorders, cardiovascular diseases, and genetic illnesses. Its portfolio of drug candidates includes SG295...
Can you invest in Sana Biotechnology, Inc.?
Yes. Sana Biotechnology, Inc. trades publicly on NASDAQ as SANA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Sana Biotechnology, Inc.
Detailed equity research is provided by MarketSnap.